Table 1 Demographic and clinical characteristics of 62 patients with thymic epithelial tumor
Variables | (N = 62) |
|---|---|
Sex, males | 33 (53.2%) |
Age, years | 56.31 ± 12.80 |
Myasthenia gravis | 11 (17.7%) |
Pre-operative tumor size, cm | 6.11 ± 3.83 |
Clinical T staging | |
T1 | 26 (41.9%) |
T2 | 12 (19.4%) |
T3 | 22 (35.5%) |
T4 | 2 (3.2%) |
Pathological WHO histological classification | |
A | 8 (12.9%) |
AB | 14 (22.6%) |
B1 | 4 (6.5%) |
B2 | 20 (32.3%) |
B3 | 2 (3.2%) |
Carcinoma | 14 (22.6%) |
Pathological Masaoka staging | |
I | 21 (33.9%) |
II | 17 (27.4%) |
III | 11 (17.7%) |
IV | 13 (21%) |
Pathological T staging | |
T1 | 38 (61.3%) |
T2 | 4 (6.5%) |
T3 | 13 (21%) |
T4 | 7 (11.3%) |
Pathological M staging | |
M1a | 11 (17.7%) |
M1b | 2 (3.2%) |